Shares of Genus plc (LON:GNS) have been assigned a consensus rating of “Hold” from the six brokerages that are covering the firm, Marketbeat reports. Four equities research analysts have rated the stock with a hold rating and two have given a buy rating to the company. The average 12 month target price among analysts that have issued a report on the stock in the last year is GBX 2,217 ($29.84).
A number of research firms recently weighed in on GNS. N+1 Singer reaffirmed a “buy” rating on shares of Genus in a report on Thursday, November 16th. Peel Hunt reaffirmed a “buy” rating and set a GBX 2,600 ($34.99) price target on shares of Genus in a report on Wednesday, November 15th. Liberum Capital lowered shares of Genus to a “hold” rating and raised their price target for the company from GBX 1,950 ($26.24) to GBX 2,100 ($28.26) in a report on Wednesday, September 13th. Numis Securities reaffirmed a “hold” rating and set a GBX 1,815 ($24.43) price target on shares of Genus in a report on Thursday, September 7th. Finally, Kepler Capital Markets reaffirmed a “hold” rating and set a GBX 2,353 ($31.67) price target on shares of Genus in a report on Wednesday, November 15th.
Shares of Genus (LON:GNS) traded down GBX 9 ($0.12) during mid-day trading on Thursday, hitting GBX 2,397 ($32.26). 56,705 shares of the stock were exchanged, compared to its average volume of 59,713. Genus has a fifty-two week low of GBX 1,652 ($22.23) and a fifty-two week high of GBX 2,500 ($33.65).
Genus Company Profile
Genus plc is an animal genetics company, which provides farmers with genetics that enable them to produce animal protein, in the form of meat and milk. The Company’s segments include Genus PIC, Genus ABS, Genus Asia, and Research and Development. The Genus PIC segment is engaged in porcine sales business, excluding Asia, and serves porcine customers in North America, Latin America and Europe.
Receive News & Ratings for Genus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genus and related companies with MarketBeat.com's FREE daily email newsletter.